Drug advertisements in two dermatology journals: A critical comparison of IJDVL and JAAD

Gahalaut, Pratik; Chauhan, Suvarcha; Mishra, Nitin; Rastogi, Madhurkant; Thakur, Ramesh

doi:10.4103/0378-6323.129381

Cited by 10 publications

(10 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[1] Although the financial support to a scientific journal rendered by advertisements is a reality, editors have a responsibility to guide the readers. With this in mind, framing of an advertisement policy for the journal and having a committee to scrutinize advertisements should help in sorting this issue to the advantage of all the stakeholders.…”

mentioning

confidence: 99%

Streamlining advertisements: Editorial perspective

Khopkar¹

2014

Indian J Dermatol Venereol Leprol

View full text Add to dashboard Cite

mentioning

confidence: 99%

Streamlining advertisements: Editorial perspective

Khopkar¹

2014

Indian J Dermatol Venereol Leprol

View full text Add to dashboard Cite

“…They may also modulate the prescribing behavior of physicians without their knowledge. 1 Journal advertisements attract physicians' attention because they are visually appealing. 2 This may be one of the ways of getting scientific and educational information and keeping up-to-date with newly marketed drugs.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of Scientific Advertisements of Pharmaceutical Products as Per UCPMP Guidelines

Patil¹,

Ligade²,

Muragundi³

2017

JYP

View full text Add to dashboard Cite

Background: Uniform Code for Pharmaceutical Marketing Practices (UCPMP), issued by the Department of Pharmaceuticals, introduced in India after several years of deliberations. The UCPMP is to be voluntarily adopted and implemented by pharmaceutical companies. The main aim of study was to evaluate the scientific advertisements of pharmaceutical products as per uniform code of pharmaceutical marketing practices (UCPMP) draft guidelines Methodology: Printed copies of the journals in Manipal University Health Sciences Library were scrutinised to identify Indian journals containing advertisements. All the selected journals published during the time period from Jan, 2012 to Dec, 2014 were further scrutinised to identify advertisements for evaluation. All the selected advertisements were evaluated for its content as per the UCPMP guidelines and the observations were recorded in the data collection sheet prepared for the study. The collected data was coded and entered into SPSS software. The results are presented in the form of descriptive statistic. Results: Some parameters such as claims-safe (85.9%), no side effect (98.9%), no toxic hazards (99.2%), word new (96.3%), brand name of competitors (99.6%), name and address of company (93.8%), method of administration (71%), method of use (88%), additional information on request (65.5%) and name and photo of healthcare professionals (97.9%) for full ads almost adhere to guidelines. Whereas some parameter such as claims without references (56.8%), date of advertisement (25.3%), adverse reaction, warnings, precaution for use and contraindications (50.2%), recommended dose (55.6%) for full ads do not follow guidelines. Conclusion: The present study has clearly shown the discrepancies in the usage of references for the substantiation of claims made and recommended dose. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

show abstract

“…"Ethical criteria for medicinal drug promotion" by WHO, "Code of pharmaceutical marketing practices" by International Federation of Pharmaceutical Manufacturers and Association (IFPMA) have been issued for regulation of drug promotional activities at international level so as to support and encourage the improvement of health care through the rational use of drugs. 8 However, there is no legislation in India that makes these guidelines to be strictly complied by pharmaceutical companies. A number of studies have shown that the drug promotional literature in India often provides incomplete and poor quality of essential information.…”

mentioning

confidence: 99%